| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C67-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2010-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12327481669309c759a345a2e7c803df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_138e0cf80547fe19470b9055c76c5a3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e95fb0bf64e26148ce693e205112828a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3405cd7e2d95c919d1c3831d70f80a25 |
| publicationDate |
2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120053245-A |
| titleOfInvention |
Anticancer composition containing gallic acid derivative as an active ingredient |
| abstract |
The present invention relates to a novel gallic acid derivative prepared by using gallic acid as a basic structure, a preparation method thereof, and an anticancer composition using the same. The gallic acid derivative of the present invention exhibits effective anticancer activity by inhibiting the activity of HAT (histone acetyltransferase), and is safe because it has a basic structure of natural acid gallic acid. The present invention also provides basic data of medicines and foods of gallic acid derivatives having anticancer activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017099531-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101651605-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200008395-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10696623-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019500421-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108017585-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017066965-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102924318-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102924318-B |
| priorityDate |
2010-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |